KaliVir Immunotherapeutics
multiple therapies, one virus.KALIVIR is developing cutting edge, next-generation oncolytic viral immunotherapy programs for treatment of cancer.
$14M Series A ·
Source: fundraisingfox.com
Funding history ↓Signals
KaliVir Immunotherapeutics | 2618 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $14M | — | fundraisingfox.com |
Timeline
- X account created
- Website created
Companies like KaliVir Immunotherapeutics
CCytovation$6M Series A · Apr 2025
VVyriad$25M Series B+ · Jan 2026
CCancerPathGGC TherapeuticsSeries A · Sep 2024
MMetabolic Psychiatry Labs
KKopra BioSeed · Jun 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/kalivir-immunotherapeutics (get a free API key).